Market Place
Sourcing Support
Versameb Announces Publication in Molecular Therapy
12 Dec 2023 //
PR NEWSWIRE
Versameb Names Dr. Alexandre LeBeaut as Chair of the Board of Directors
05 Dec 2023 //
PR NEWSWIRE
Touchlight’s enzymatic doggybone DNA used in manufacture of Versameb’s VMB-100
21 Nov 2023 //
BUSINESSWIRE
Versameb Strengthens its Board of Directors
11 Jul 2023 //
PR NEWSWIRE
Versameb Appoints Professor Roger Dmochowski as Chief Medical Officer
21 Jun 2023 //
PR NEWSWIRE
Touchlight signs supply agreement for Versameb`s pipeline
07 Mar 2022 //
ENDPTS
Touchlight and Versameb Enter Development & Manufacturing Pipeline Agreement
01 Mar 2022 //
PRESS RELEASE
Versameb to present novel data on its lead asset, VMB-100
03 Nov 2021 //
PRNEWSWIRE
Versameb Announces Management Update
08 Jan 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.